Aster Capital Management (Difc) LTD Amicus Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 2,486 shares of FOLD stock, worth $25,779. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,486Holding current value
$25,779% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
630KPut Options Held
669K-
Vanguard Group Inc Valley Forge, PA28.8MShares$299 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$291 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$253 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$249 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$240 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.91B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...